Timing of 3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase inhibitor initiation and allograft vasculopathy progression and outcomes in heart transplant recipients

AIMS: Early studies from the 1990s have shown that statins improve survival and attenuate cardiac allograft vasculopathy (CAV). However, little contemporary data are available on the incremental benefit of statins with the current use of new‐generation immunosuppressive agents and the use of coronar...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:ESC Heart Fail
Autors principals: Asleh, Rabea, Briasoulis, Alexandros, Pereira, Naveen L., Boilson, Barry A., Edwards, Brooks S., Adigun, Rosalyn, Maltais, Simon, Daly, Richard C., Lerman, Amir, Kushwaha, Sudhir S.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2018
Matèries:
Original Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6300821/
https://ncbi.nlm.nih.gov/pubmed/30019530
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12329
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars